Female‐friendly focus: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

Wenger, Nanette K.

doi:10.1002/clc.23218

Cited by 20 publications

(17 citation statements)

References 27 publications

(27 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

Section: Methodsmentioning

confidence: 99%

“…In the second sensitivity analysis, we defined hypertension based on the 2019 American College of Cardiology and American Heart Association (ACC/AHA) Guideline as systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥80 mm Hg. 38 Patient and public involvement There was no patient or public involvement in the design, conduct, reporting, or dissemination plans of our research. Hg, respectively, and the prevalence of hypertension was 5.7%.…”

Section: Sensitivity Analysesmentioning

confidence: 99%

See 1 more Smart Citation

Gravidity, parity, blood pressure and mortality among women in Bangladesh from the HEALS cohort

et al. 2020

View full text Add to dashboard Cite

ObjectivesDespite a hypothesised connection of reproductive history with hypertension and mortality, the nature of this association is poorly characterised. We evaluated the association of parity and gravidity with blood pressure, hypertension and all-cause mortality.DesignProspective cohort study.SettingHealth Effects of Arsenic Longitudinal Study cohort in rural Bangladesh.ParticipantsThere were 21 634 Bangladeshi women recruited in 2000–2002, 2006–2008 and 2010–2014 included in the present analysis.MethodsReproductive history was ascertained through an interviewer-administered questionnaire at the baseline visit. Blood pressure was measured by a trained study physician following a standard protocol at the baseline visit. Vital status was ascertained at the biennial follow-up of study participants through June 2017. Linear and logistic regression models estimated the relationship between parity and gravidity with blood pressure and hypertension, respectively. Cox proportional hazards models estimated the relationship with all-cause mortality only among women aged >45 years.ResultsDiastolic blood pressure was lowest in women with parity one (reference) and elevated in nulliparous women (adjusted % change=3.12; 95% CI 1.93 to 4.33) and women with parity >2 (adjusted % change=1.71; 95% CI 1.12 to 2.31). The associations with nulliparity were stronger for women aged >45 years. Similar association patterns were observed with hypertension. Further, in nulliparous women aged >45 years, 265 deaths (6.6%) were ascertained during the follow-up period (median follow-up time=8 years), and we observed suggestive elevated risks of all-cause mortality (adjusted HR 3.83; 95% CI 0.74 to 19.78). The relationships between reproductive history, blood pressure, hypertension and mortality were similar when modelling reproductive history as gravidity rather than parity.ConclusionsFor women in rural Bangladesh, nulliparity and nulligravidity appear to be associated with higher blood pressure and subsequent elevated risk of mortality.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Sensitivity Analysesmentioning

confidence: 99%

Gravidity, parity, blood pressure and mortality among women in Bangladesh from the HEALS cohort

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Daily aspirin use resulted in a 37% reduction in the risk for developing advanced fibrosis . This finding may impact the recently revised guidelines regarding the non‐recommendation of aspirin for primary prevention of cardiovascular disease …”

mentioning

confidence: 88%

Non‐alcoholic fatty liver disease (NAFLD)—Treat to target, but the goalposts are in the wrong place

2019

View full text Add to dashboard Cite

“…Aspirin for primary prevention is associated with a higher risk reduction for ischemic stroke in females and for MI in males [ 42 ].…”

Section: Non Atherogenic Cad In Womenmentioning

confidence: 99%

Cardiovascular disease in women: Executive summary of the expert panel statement of women in cardiology of the hellenic cardiological society

Chrysοhoou

Aggeli

Avgeropoulou

et al. 2020

Hellenic Journal of Cardiology

View full text Add to dashboard Cite

The perception that women represent a low risk population for cardiovascular (CV) disease (CVD) needs to be reconsidered. Starting from risk factors, women are more likely to be susceptible to unhealthy behaviors and risk factors that have different impact on CV morbidity and mortality compared to men. Despite the large body of evidence as regards the effect of lifestyle factors on the CVD onset, the gender-specific effect of traditional and non-traditional risk factors on the prognosis of patients with already established CVD has not been well investigated and understood. Furthermore, CVD in women is often misdiagnosed, underestimated and undertreated. Women also experience hormonal changes from adolescence till elder life that affect CV physiology. Unfortunately, in most of the clinical trials women are under-represented, leading to limited knowledge of CV and systemic impact effects of several treatment modalities on women’s health. Thus, in this consensus a group of female Cardiologists from the Hellenic Society of Cardiology present the special features of CVD in women: the different needs in primary and secondary prevention, as well as therapeutic strategies, that may be implemented in daily clinical practice in order to eliminate underestimation and undertreatment of CVD in female population.

show abstract

Female‐friendly focus: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

Cited by 20 publications

References 27 publications

Gravidity, parity, blood pressure and mortality among women in Bangladesh from the HEALS cohort

Gravidity, parity, blood pressure and mortality among women in Bangladesh from the HEALS cohort

Non‐alcoholic fatty liver disease (NAFLD)—Treat to target, but the goalposts are in the wrong place

Cardiovascular disease in women: Executive summary of the expert panel statement of women in cardiology of the hellenic cardiological society

Contact Info

Product

Resources

About